Shire Receives EMA Approval of Lexington Factory 03/01/2012Posted by Morse, Barnes-Brown Pendleton in Client News.
Tags: EMA, european medicines agency, Shire, vpriv
On February 22nd, MBBP client Shire announced that the European Medicines Agency (EMA) has approved the production of its VPRIV enzyme replacement therapies to be made at Shire’s new factory in Lexington, MA. With the additional capacity of a second EMA approved facility, Shire will have the ability to significantly increase the global supply of VPRIV while also providing the company with more manufacturing flexibility.
Please see Shire’s full press release for more information.